Zobrazeno 1 - 10
of 20 013
pro vyhledávání: '"SLE"'
Autor:
Eman Yahya Zakarieya, Mervat Abd Elhamid Reda, Nayera Zaghloul Saber, Haytham Mohamed Nasser, Ahmed Ibrahim Hammad
Publikováno v:
Egyptian Rheumatology and Rehabilitation, Vol 51, Iss 1, Pp 1-10 (2024)
Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune disease with diverse manifestations, which resembles a clinical challenge to be managed. Lupus nephritis is a life-threatening condition as about 10% of patients develop chronic
Externí odkaz:
https://doaj.org/article/9f22a1eee8da4eecb3f26a3b030a760a
Publikováno v:
Journal of Family Medicine and Primary Care, Vol 13, Iss 10, Pp 4616-4622 (2024)
Aims To study the pattern of physical growth and pubertal changes in adolescent girls with Systemic Lupus Erythematosus (SLE). Methods and Material Weight, height, BMI, waist and hip circumference among 50 adolescent SLE girls (aged 8–17 years) wer
Externí odkaz:
https://doaj.org/article/b62f25666680406187d8148c03ef1f4d
Publikováno v:
BMC Rheumatology, Vol 8, Iss 1, Pp 1-14 (2024)
Abstract Background Systemic Lupus Erythematosus (SLE) is a multifaceted autoimmune disorder characterized by diverse clinical manifestations, including a significant prevalence of headaches. This cross-sectional study aimed to thoroughly explore the
Externí odkaz:
https://doaj.org/article/7a6a4d09ffaf492ea5fe717b0fb69713
Publikováno v:
Zhongguo shuxue zazhi, Vol 37, Iss 10, Pp 1189-1192 (2024)
Objective To analyze the clinical outcomes of a patient with thrombotic thrombocytopenic purpura(TTP) as the starting performance who was considered as systemic lupus erythematosus(SLE) under multiple abnormal autoantibodies, and summarize the treatm
Externí odkaz:
https://doaj.org/article/1577ed7dbc8f432f99b0fe7380e6c10b
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-11 (2024)
Abstract Background Low-dose IL-2 (Ld-IL2) has shown favorable therapeutic effects in systemic lupus erythematosus (SLE) therapy. However, previous clinical trials reported an SLE Responder Index-4 (SRI-4) response rate of 65.52%-68%, with approximat
Externí odkaz:
https://doaj.org/article/90bef5d50c0e4e72b7019607f833b32a
Publikováno v:
Exploration of Immunology, Vol 4, Iss 5, Pp 640-657 (2024)
The impaired function of regulatory T (Treg) cells and the imbalance of Treg/Th17 cells play a central role in developing autoimmune diseases such as systemic lupus erythematosus (SLE). Treg cells are crucial for maintaining immune homeostasis and to
Externí odkaz:
https://doaj.org/article/59550e72828c4c598e075e79010c057c
Autor:
Hawraa S. Al-Mozani, Sajidah F. Hasan
Publikováno v:
Medical Journal of Babylon, Vol 21, Iss 3, Pp 599-605 (2024)
Background:The autoimmune disease systemic lupus erythematosus (SLE) can cause multisystemic tissue damage because of the interaction between the autoantibodies and self-antigens. The complement system has a role in the development of the disease act
Externí odkaz:
https://doaj.org/article/bcd3fc940b144ea5b8e90d258ddde919
Publikováno v:
Arthritis Research & Therapy, Vol 26, Iss 1, Pp 1-9 (2024)
Abstract Objective To investigate the efficacy and safety of belimumab in the treatment of systemic lupus erythematosus (SLE) in a real-world setting and provide a valuable reference for clinical treatment. Methods In this retrospective study, 101 pa
Externí odkaz:
https://doaj.org/article/3ec2cff0b3454f8fba342086070b07f8
Publikováno v:
Onco, Vol 4, Iss 3, Pp 232-240 (2024)
The use of chimeric antigen receptors (CAR T-cells) for the treatment of patients with malignant haematological diseases has become a well-established application for conditions such as refractory or relapsed B-cell acute lymphoblastic leukaemia (B-A
Externí odkaz:
https://doaj.org/article/681b84c48d244b28a1b50f50a66d3c15